NYSE:NVRO - Nevro Stock Price, Forecast & News

Nevro's stock was trading at $109.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NVRO stock has decreased by 18.5% and is now trading at $89.45. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nevro in the last year. There are currently 1 sell rating, 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nevro.

Nevro is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Nevro.

Nevro Corp (NYSE:NVRO) posted its quarterly earnings data on Tuesday, February, 25th. The medical equipment provider reported ($0.44) EPS for the quarter, beating the consensus estimate of ($0.62) by $0.18. The medical equipment provider had revenue of $114.37 million for the quarter, compared to analysts' expectations of $110.83 million. Nevro had a negative net margin of 26.57% and a negative return on equity of 49.96%. View Nevro's earnings history.

Nevro issued an update on its first quarter 2020 After-Hours earnings guidance on Wednesday, April, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $86.4-86.9 million, compared to the consensus revenue estimate of $96.96 million.

12 Wall Street analysts have issued 12 month price targets for Nevro's stock. Their forecasts range from $65.00 to $158.00. On average, they expect Nevro's stock price to reach $121.50 in the next twelve months. This suggests a possible upside of 35.8% from the stock's current price. View analysts' price targets for Nevro.

Media stories about NVRO stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Nevro earned a news impact score of -3.3 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutNevro.

Nevro saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 2,539,800 shares, an increase of 10.9% from the February 27th total of 2,290,000 shares. Based on an average daily trading volume, of 397,600 shares, the short-interest ratio is currently 6.4 days. Approximately 8.4% of the shares of the company are sold short. View Nevro's Current Options Chain.

Some companies that are related to Nevro include Insulet (PODD), Hill-Rom (HRC), ABIOMED (ABMD), Novocure (NVCR), Penumbra (PEN), Haemonetics (HAE), Globus Medical (GMED), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), NuVasive (NUVA), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Cantel Medical (CMD) and Inspire Medical Systems (INSP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nevro investors own include AT&T (T), NVIDIA (NVDA), Gilead Sciences (GILD), AbbVie (ABBV), Micron Technology (MU), Adobe (ADBE), Incyte (INCY), Ionis Pharmaceuticals (IONS), Starbucks (SBUX) and ABIOMED (ABMD).

Nevro trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVRO."

Shares of NVRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NVRO stock can currently be purchased for approximately $89.45.

Nevro has a market capitalization of $2.85 billion and generates $390.26 million in revenue each year. The medical equipment provider earns $-103,690,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. Nevro employs 804 workers across the globe. View additional information about Nevro.

The official website for Nevro is http://www.nevro.com/.

Nevro's mailing address is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. The medical equipment provider can be reached via phone at 650-251-0005 or via email at [email protected]